share_log

Acrobiosystems Co.,Ltd.'s (SZSE:301080) Most Bullish Insider, CEO Yiding Chen Must Be Pleased With the Recent 10% Gain

Acrobiosystems Co.,Ltd.'s (SZSE:301080) Most Bullish Insider, CEO Yiding Chen Must Be Pleased With the Recent 10% Gain

Acrobiosystems 公司, Ltd. 's (SZSE: 301080) 最看涨的内幕人士,首席执行官陈一丁一定对最近10%的涨幅感到满意
Simply Wall St ·  05/06 18:47

Key Insights

关键见解

  • AcrobiosystemsLtd's significant insider ownership suggests inherent interests in company's expansion
  • A total of 5 investors have a majority stake in the company with 51% ownership
  • Institutions own 25% of AcrobiosystemsLtd
  • AcrobioSystemsLtd拥有大量内部所有权,这表明公司的扩张具有固有的利益
  • 共有5名投资者持有该公司的多数股权,所有权为51%
  • 机构拥有AcrobiosystemsLtd25%的股份

To get a sense of who is truly in control of Acrobiosystems Co.,Ltd. (SZSE:301080), it is important to understand the ownership structure of the business. With 37% stake, individual insiders possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

了解谁真正控制了 Acrobiosystems Co., Ltd.(深圳证券交易所代码:301080),了解企业的所有权结构很重要。个人内部人士持有37%的股份,是公司的最大股份。换句话说,该集团将从对公司的投资中获得最多(或损失最大)。

As a result, insiders were the biggest beneficiaries of last week's 10% gain.

结果,内部人士是上周10%涨幅的最大受益者。

Let's take a closer look to see what the different types of shareholders can tell us about AcrobiosystemsLtd.

让我们仔细看看不同类型的股东能告诉我们关于AcrobiosystemsLtd的信息。

ownership-breakdown
SZSE:301080 Ownership Breakdown May 6th 2024
SZSE: 301080 所有权明细 2024 年 5 月 6 日

What Does The Institutional Ownership Tell Us About AcrobiosystemsLtd?

关于AcrobiosystemsLtd,机构所有权告诉我们什么?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

机构投资者通常将自己的回报与常见指数的回报进行比较。因此,他们通常会考虑收购相关基准指数中包含的大型公司。

As you can see, institutional investors have a fair amount of stake in AcrobiosystemsLtd. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at AcrobiosystemsLtd's earnings history below. Of course, the future is what really matters.

如你所见,机构投资者持有AcrobiosystemsLtd的相当数量的股份。这表明专业投资者有一定的信誉。但是我们不能仅仅依靠这一事实,因为机构有时会像所有人一样进行不良投资。如果多家机构同时改变对股票的看法,你可能会看到股价快速下跌。因此,值得在下面查看AcrobioSystemsLtd的收益记录。当然,未来才是真正重要的。

earnings-and-revenue-growth
SZSE:301080 Earnings and Revenue Growth May 6th 2024
SZSE: 301080 收益和收入增长 2024 年 5 月 6 日

Hedge funds don't have many shares in AcrobiosystemsLtd. The company's CEO Yiding Chen is the largest shareholder with 24% of shares outstanding. In comparison, the second and third largest shareholders hold about 10% and 8.9% of the stock. Interestingly, the third-largest shareholder, Jingyun Miao is also a Member of the Board of Directors, again, indicating strong insider ownership amongst the company's top shareholders.

对冲基金在AcrobiosystemsLtd的股份不多。该公司首席执行官陈一丁是最大股东,已发行股份为24%。相比之下,第二和第三大股东持有约10%和8.9%的股份。有趣的是,第三大股东苗景云也是董事会成员,这再次表明公司最大股东拥有强大的内部所有权。

On looking further, we found that 51% of the shares are owned by the top 5 shareholders. In other words, these shareholders have a meaningful say in the decisions of the company.

进一步观察,我们发现前五名股东持有51%的股份。换句话说,这些股东在公司的决策中拥有有意义的发言权。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

研究机构所有权是衡量和筛选股票预期表现的好方法。通过研究分析师的情绪也可以达到同样的目的。有很多分析师在报道该股,因此可能也值得一看他们的预测。

Insider Ownership Of AcrobiosystemsLtd

AcrobiosystemsLtd 的内部所有权

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

公司内部人员的定义可能是主观的,并且在不同的司法管辖区之间确实有所不同。我们的数据反映了个人内部人士,至少涵盖了董事会成员。公司管理层对董事会负责,后者应代表股东的利益。值得注意的是,有时高层管理人员自己也是董事会成员。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多数人认为内部所有权是积极的,因为这可能表明董事会与其他股东关系良好。但是,在某些情况下,过多的权力集中在该群体中。

It seems insiders own a significant proportion of Acrobiosystems Co.,Ltd.. Insiders have a CN¥1.9b stake in this CN¥5.1b business. We would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling.

内部人士似乎拥有Acrobiosystems公司的很大一部分股份。,有限公司。业内人士持有这项51亿元人民币的业务19亿加元的股份。我们可以说这表明了与股东的一致性,但值得注意的是,该公司仍然很小;一些内部人士可能已经创立了该公司。你可以点击这里查看这些内部人士是否在买入或卖出。

General Public Ownership

一般公有制

With a 25% ownership, the general public, mostly comprising of individual investors, have some degree of sway over AcrobiosystemsLtd. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

AcrobioSystemsLtd拥有25%的所有权,主要由个人投资者组成的公众对AcrobiosystemsLtd有一定程度的影响力。尽管这种所有权规模可能不足以影响对他们有利的政策决定,但它们仍然可以对公司政策产生集体影响。

Private Company Ownership

私人公司所有权

It seems that Private Companies own 13%, of the AcrobiosystemsLtd stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

看来私营公司拥有AcrobioSystemsLtd13%的股份。私营公司可能是关联方。有时,内部人士通过控股私营公司而对上市公司拥有权益,而不是以个人身份拥有权益。尽管很难得出任何宽泛的结论,但值得注意的是,这是一个需要进一步研究的领域。

Next Steps:

后续步骤:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 3 warning signs for AcrobiosystemsLtd you should be aware of, and 1 of them is concerning.

我觉得看看究竟谁拥有一家公司非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。一个很好的例子:我们发现了你应该注意的AcrobiosystemsLTD的3个警告信号,其中一个令人担忧。

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但归根结底,决定这家企业所有者的表现的是未来,而不是过去。因此,我们认为最好看一下这份免费报告,该报告显示了分析师是否预测了更光明的未来。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的数字是使用过去十二个月的数据计算得出的,这些数据是指截至财务报表日期当月最后一天的12个月期间。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发